Abstract
Herein we report the case of a 37-year-old woman with recurrence of lupus nephritis (LN) in a renal allograft during pregnancy. She had developed end-stage renal disease due to LN and was put on hemodialysis at the age of 26 years. She underwent kidney transplantation at the age 28 years. Maintenance immunosuppressants included methylprednisolone, tacrolimus, and mycophenolate mofetil, which were changed to azathioprine when she desired pregnancy. The renal allograft function remained stable and seemingly disease-free until proteinuria and functional decline occurred during the pregnancy (age: 34 years). The baby was delivered by performing a cesarean section at 33 weeks of gestation. Renal allograft biopsy revealed crescent formation. Light microscopy revealed tuft necrosis and endocapillary proliferation. Immunofluorescence microscopy revealed the deposition of immunoglobulin G and C1q. A recurrence of LN (ISN/RPS class IV-G [A/C]) was diagnosed, and the patient was treated with pulse steroid therapy and azathioprine was replaced with mycophenolate mofetil. This treatment improved acute or active lesions of LN and temporarily benefited the renal allograft function. Unfortunately, there were irreversible chronic changes and a gradual decline in the renal allograft function.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13730-021-00659-x/MediaObjects/13730_2021_659_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13730-021-00659-x/MediaObjects/13730_2021_659_Fig2_HTML.png)
Similar content being viewed by others
References
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Góral A, de Ramón E, Fernández-Nebro A, Galeazzi M. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. .A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine. 1999;1(3):167–75.
Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD, LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152–60.
Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology. 2006;45(9):1144–7.
Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006;33(8):1563–9.
Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, Montagnino G, Meroni P, Messa P, Ponticelli C. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005;45(5):903–11.
Yu TM, Chen YH, Lan JL, Cheng CH, Chen CH, Wu MJ, Shu KH. Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation. Lupus. 2008;17(7):687–94.
Ghafari A, Etemadi J, Ardalan MR. Renal transplantation in patients with lupus nephritis: a single-center experience. Transplant Proc. 2008;40(1):143–4.
Burgos PI, Perkins EL, Pons-Estel GJ, Kendrick SA, Liu JM, Kendrick WT, Cook WJ, Julian BA, Alarcón GS, Kew CE. Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum. 2009;60(9):2757–66.
Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, LeClercq B. Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol. 2010;21(7):1200–7.
Yu TM, Wen MC, Li CY, Cheng CH, Wu MJ, Chen CH, Chen YH, Ho HC, Shu KH. Impact of recurrent lupus nephritis on lupus kidney transplantation. Clin Rheumatol. 2012;31(4):705–10.
Oliveira CS, de Oliveira I, Bacchiega AB, Klumb EM, Albuquerque EM, Souza E, Suassuna JH, Ribeiro FM. Renal transplantation in lupus nephritis: a Brazilian cohort. Lupus. 2012;21(5):570–4.
Wagner CS, Malafrontle P, Demetrio DP, de Souza JF, Sens YA. Outcomes in renal transplant recipients with lupus nephritis: experience at a single center. Ren Fail. 2014;36(6):912–5.
Nieto-Ríos JF, Serna-Higuita LM, Builes-Rodriguez SA, Restrepo-Correa RC, Aristizabal-Alzate A, Ocampo-Kohn C, Serna-Campuzano A, Cardona-Díaz N, Giraldo-Ramirez ND, Zuluaga-Valencia GA. Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy. Colomb Med. 2016;47(1):51–8.
Naranjo-Escobar J, Manzi E, Posada JG, Mesa L, Echeverri GJ, Duran C, Schweneiberg J, Caicedo LA, Villegas JI, Tobon GJ. Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience. Lupus. 2017;26(11):1157–65.
Ramirez-Sandoval JC, Chavez-Chavez H, Wagner M, Vega-Vega O, Morales-Buenrostro LE, Correa-Rotter R. Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort. Lupus. 2018;27(8):1303–11.
Park ES, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW. Renal outcome after kidney-transplantation in Korean patients with lupus nephritis. Lupus. 2018;27(3):461–7.
Horta-Baas G, Camargo-Coronel A, Miranda-Hernández DG, Gónzalez-Parra LG, del Socorro R-F, Pérez-Cristóbal M. Renal transplantation in systemic lupus erythematosus: comparison of graft survival with other causes of end-stage renal disease. Reumatol Clín. 2019;15(3):140–5.
Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H. Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis. 2010;69(8):1484–7.
Çeltİk A, Şen S, Tamer AF, Yılmaz M, Sarsık B, Özkahya M, Başçı A, Töz H. Recurrent lupus nephritis after transplantation: clinicopathological evaluation with protocol biopsies. Nephrology. 2016;21(7):601–7.
Alshohaib S. Outcome of pregnancy in patients with inactive systemic lupus erythromatosus and minimal proteinuria. Saudi J Kidney Dis Transplant. 2009;20(5):802.
Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2):519–25.
Carvalheiras G, Vita P, Marta S, Trovão R, Farinha F, Braga J, Rocha G, Almeida I, Marinho A, Mendonça T, Barbosa P. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol. 2010;38(2–3):302–6.
Saavedra MA, Cruz-Reyes C, Vera-Lastra O, Romero GT, Cruz-Cruz P, Arias-Flores R, Jara LJ. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol. 2012;31(5):813–9.
Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, De Liso F. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016;74:194–200.
Chen TK, Gelber AC, Witter FR, Petri M, Fine DM. Renal biopsy in the management of lupus nephritis during pregnancy. Lupus. 2015;24(2):147–54.
Cohen-Solal JF, Jeganathan V, Grimaldi CM, et al. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol. 2006;305:67–88.
Grimaldi CM. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol. 2006;18(5):456–61.
Baines MG, Millar KG, Mills P. Studies of complement levels in normal human pregnancy. Obstet Gynecol. 1974;43(6):806–10.
Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum. 1992;35(1):55–61.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors have declared no competing interest.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number RIN A19-097) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent obtained from the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shinzato, T., Shimizu, T., Iwami, D. et al. Recurrent lupus nephritis in renal allograft triggered by pregnancy. CEN Case Rep 11, 237–241 (2022). https://doi.org/10.1007/s13730-021-00659-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-021-00659-x